Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery (MAGIPAC): A Randomized Clinical Trial.
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Pancreatic cancer patients considered to have a locally resectable or borderline resectable tumor by the local hepato-pancreato-biliary multidisciplinary team board
• No liver metastases on CT
• At least 18 years old and able to provide informed consent
• Expected pancreatic ductal adenocarcinoma based on CT scan
Locations
Other Locations
Denmark
Aalborg University Hospital
RECRUITING
Aalborg
Aarhus University Hospital
RECRUITING
Aarhus
Rigshospitalet
RECRUITING
Copenhagen
Contact Information
Primary
Jakob Kirkegård, MD, PhD
jakob.kirkegaard@auh.rm.dk
+4522900604
Backup
Frank Mortensen, MD, DMSc
frmort@rm.dk
+45222517296
Time Frame
Start Date: 2022-08-30
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 200
Treatments
Experimental: Preoperative MRI
MRI before surgery.
Related Therapeutic Areas
Sponsors
Leads: University of Aarhus
Collaborators: Aalborg University Hospital, Rigshospitalet, Denmark